Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

C. Faivre-Finn; F. Blackhall; N. Thatcher; P. Taylor; L. Ashcroft; C. Rowbottom; P. Lorigan

doi:10.1200/jco.2008.26.15_suppl.7583

Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7583 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7583-7583 ◽

Cited By ~ 2

Author(s):

C. Faivre-Finn ◽

F. Blackhall ◽

N. Thatcher ◽

P. Taylor ◽

L. Ashcroft ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

High Dose ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Once Daily

Download Full-text

Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited-stage small cell lung cancer (LS-SCLC)

Lung Cancer ◽

10.1016/s0169-5002(09)70035-2 ◽

2009 ◽

Vol 63 ◽

pp. S11-S12

Author(s):

H. Sheikh ◽

F. Blackhall ◽

P. Lorigan ◽

P. Taylor ◽

L. Ashcroft ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

High Dose ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Once Daily

Download Full-text

Long-term Toxicity Report From a Phase II Study of Accelerated Twice-Daily (BD) versus High Dose Once-Daily (OD) Thoracic Radiotherapy (RT) With Concurrent Chemotherapy for Limited-Stage Small Cell Lung Cancer (LS-SCLC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.1104 ◽

2011 ◽

Vol 81 (2) ◽

pp. S589 ◽

Cited By ~ 2

Author(s):

C. Faivre-Finn ◽

F. Blackhall ◽

L. Ashcroft ◽

N. Thatcher ◽

P. Taylor ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

High Dose ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Once Daily

Download Full-text

Phase II study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III non-small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7017 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7017-7017

Author(s):

J. Y. Chang ◽

R. Komaki ◽

C. Lu ◽

H. Y. When ◽

P. Allen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Proton Therapy ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

High Dose ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70153-2 ◽

2006 ◽

Vol 2006 ◽

pp. 218-219

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Radiation Therapy Oncology Group ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text

Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)

Lung Cancer ◽

10.1016/j.lungcan.2021.04.020 ◽

2021 ◽

Vol 156 ◽

pp. 82-90

Author(s):

NaiBin Chen ◽

QiWen Li ◽

SiYu Wang ◽

Mai Xiong ◽

YiFeng Luo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Locoregional Recurrence ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Complete Resection ◽

Small Cell ◽

Small Cell Lung ◽

Fractionated Radiotherapy

Download Full-text

P-774 Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by innotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Oncology Group Trial

Lung Cancer ◽

10.1016/s0169-5002(05)81267-x ◽

2005 ◽

Vol 49 ◽

pp. S322 ◽

Cited By ~ 1

Author(s):

T. Kashii ◽

H. Saito ◽

S. Negoro ◽

Y. Takada ◽

Y. Ichinose ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Group Trial

Download Full-text

Negative Phase II Study of 5-Fluorouracil with High-dose Leucovorin in Non-small Cell Lung Cancer

Japanese Journal of Clinical Oncology ◽

10.1093/oxfordjournals.jjco.a039412 ◽

1990 ◽

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Negative Phase ◽

High Dose ◽

Small Cell Lung

Download Full-text

Phase II Study of Concurrent Chemotherapy with Etoposide and Cisplatin (EP) and Radiation Therapy for Unresectable Stage III Non-small Cell Lung Cancer

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.1997.44.4.776 ◽

1997 ◽

Vol 44 (4) ◽

pp. 776 ◽

Cited By ~ 1

Author(s):

Nam Hyun Hur ◽

Choon Taek Lee ◽

Jae Hag Kim ◽

Seung Mo Nam ◽

Yeon Hee Park ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6602979 ◽

2006 ◽

Vol 94 (5) ◽

pp. 625-630 ◽

Cited By ~ 58

Author(s):

P Baas ◽

J S A Belderbos ◽

S Senan ◽

H B Kwa ◽

A van Bochove ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Multicenter Phase ◽

Involved Field ◽

Involved Field Radiotherapy

Download Full-text

A phase II study of vindesine and cisplatin (VP) used concurrently with Thoracic Radiotherapy (TRT) for locally advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer ◽

10.1016/0169-5002(91)91937-7 ◽

1991 ◽

Vol 7 ◽

pp. 157

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Small Cell ◽

Thoracic Radiotherapy ◽

Small Cell Lung

Download Full-text